Asymptomatic women with a significant family history (see table below) should be referred to Clinical Genetics for assessment of family history and eligibility for screening and/or genetic testing.
Referrals are triaged by the Clinical Genetics team. Depending on the family history an assessment may be completed by letter or by sending the patient a family history questionnaire (if further information is required) or by appointment.
If appropriate, a referral for breast screening will be made by Clinical Genetics.
Please note that not all referrals will be allocated an appointment with Clinical Genetics.
Referral Guidelines
One affected relative must be a first degree relative unless through an intervening male and they must all be on the same side of the family.
Family History of Breast Cancer
Number of relatives affected with breast cancer | Family History of Breast Cancer | Low Risk | Moderate Risk | High Risk |
1 relative | FDR diagnosed > 40 years | Reassure | ||
FDR diagnosed < 40 years | Refer | |||
FDR diagnosed with breast and ovarian cancer (double primary) | Refer | |||
Male FDR at any age | Refer | |||
2 Relitives | 2 relatives both diagnosed > 60 years | Reassure | ||
FDR diagnosed < 60 years plus FDR or SDR diagnosed < 60 years | Refer | |||
FDR diagnosed with bilateral breast cancer < 60 years | Refer | |||
FDR or SDR diagnosed breast cancer < 60 years and FDR or SDR with ovarian cancer at any age | Refer | |||
3 Relitives | 3 FDR or SDR diagnosed at any age on the SAME side of the family (one must be FDR of patient or SDR via father) | Refer | ||
4 or more relitives | Diagnosed < 60 years (one must be FDR of patient or SDR via father) | Refer | ||
If there is a known genetic predisposition in the family e.g. a BRCA mutation, you can refer your patient for discussion of predictive testing and management options. |
First degree relatives: Mother father, sister, brother, daughter, son.
Second degree relatives: Grandmother, grandfather, aunt, uncle, granddaughter, grandson, niece, nephew
Patients with a low risk family history (above) are eligible for the National Breast Screening Programme from 50 years. They should NOT be referred to Genetic Services.
Patients who have had cancer – for consideration of genetic testing
Patients who have had cancer AND who meet any of the following criteria may be eligible for genetic testing:-
- Breast cancer under 40
- Triple negative breast cancer, any age
- Bilateral breast cancer, both diagnosed under 60 years
- High grade serous ovarian cancer, diagnosed any age
- THREE breast cancers in family, diagnosis under 50
- FOUR breast cancers in family, diagnosis under 60
- Families of Ashkenazi Jewish/ Polish descent with a history of breast/ovarian cancer in the family
In most families, a genetic test for cancer predisposition will not be available to family members who have NOT developed a cancer unless a pathogenic gene mutation has already been identified in an affected relative. If a mutation has been identified in the family please include in your referral the name and date of birth of the affected relative, and if possible which genetic centre they attended.
How to Refer
Please send referrals electronically
SCI-Gateway
WGH.ClinicalGenetics@nhslothian.scot.nhs.uk
or by post to
Referral Administration
SE Scotland Clinical Genetics Service
Western General Hospital
Crewe Road South
Edinburgh
EH4 2XU
If you wish to discuss a referral please call 0131 537 1116 and ask for the Duty Staff, alternatively email WGH.ClinicalGenetics@nhslothian.scot.nhs.uk
National Guidelines
Familial Breast Cancer Report: Health Improvement Scotland June 2016
Familial Breast Cancer Report
Family Breast Cancer: NICE 2013
NICE FBC Guideline 2013 Full
NICE FBC Guideline 2013 Summary
Information Leaflets
Cancer Breast, Ovarian, Prostate
Other Support Information
- Breast Cancer Care: Breast Cancer in families leaflet
- Breast Cancer Care
- Macmillan cancer support
- Sexual Health – HRT Further Info Incr Risk Breast Cancer MHRA DDL_HRT_30.08.19
- Breast Cancer at MacMillanorg.uk
- Breast Cancer at Cancer Research Uk
- National Institute for Health and Care Excellence (NICE)
- Scottish Intercollegiate Guidelines Network (SIGN)